Articles related to POLITICS & MEDICINE

“Telling someone who makes $42,000 a year that they now have the right to buy a $600 drug is like saying they have the right to buy a Mercedes. They have the right—but they can’t afford it.” —Robert Andrews, CEO, Health Transformation Alliance

“The data on leucovorin isn’t very strong… At best it can be mildly beneficial in some patients with autism. It’s not going to cure it. It’s just going to cause a massive headache for rheumatologists since they actually need to prescribe leucovorin to people with RA on methotrexate who can’t tolerate folic acid.” —Family medicine physician

Lifesaving research projects on cancer, vaccine hesitancy, and health equity are being denied funding for political reasons.

“This administration is an existential threat to vaccination in America. The professional associations will not stand idly by as our system of prevention is dismantled. This ends now.”

Cancer research infrastructure faces its most severe funding crisis in over two decades, with institutions forced to choose between maintaining current studies and preserving workforce capacity for future breakthroughs.

Prior to CDC’s Sickle Cell Data Collection program, the actual number of Americans living with sickle cell disease was unknown, with current estimates of 100,000 patients based on systematic data collection efforts now at risk.